the challenges with implementing car-t into the aml treatment landscape
Published 6 months ago • 72 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:47
challenges in using car-t therapy & btk inhibitors in patients with r/r mcl
-
1:44
challenges in developing car-t therapy for aml
-
2:23
an update on car-t therapy in aml: challenges & emerging strategies
-
1:38
challenges of car-t therapy in the real-world setting
-
4:16
the challenges with car t-cell therapy for t-all and the progress made to overcome these challenges
-
16:12
exploring the potential of car-t therapy in cll
-
8:48
what are the challenges associated with car t-cell therapy in patients with aml?
-
2:30
new leukemia treatment gives hope to cancer sufferers
-
2:08
challenges with car-t therapy in aml & insights into if-better-gated car-t cells
-
0:54
the challenges of implementing car-t approaches in lymphoma
-
25:18
addressing the major challenges to car-t therapy in aml
-
2:17
the challenges of implementing car-t therapy in cll
-
1:13
the challenges in treating aml with car t-cell therapy
-
0:52
challenges in treating infant all patients with car-t
-
1:28
addressing the challenge of bridging therapy in car-t in order to improve patient outcomes
-
3:02
the challenges of using car-t cell therapy to treat patients with cll
-
1:27
challenges in car-t therapy for myeloid malignancies
-
1:40
strategies to improve car-t outcomes in patients with lbcl
-
1:51
challenges with car t-cell therapy
-
1:16
hurdles to car-t therapy for mds & aml: t-cell fitness & lack of a uniform target antigen
-
3:17
challenges and next steps for car-t in b-cell lymphomas
-
2:16
autosct vs car-t for patients with relapsed lbcl in pr: the role of total metabolic tumor volume